View in EDS HTML Full Text PDF Full Text

Risk of progressive multifocal leukoencephalopathy in patients with multiple sclerosis treated with low‐dose natalizumab following fingolimod.

Saved in:
Bibliographic Details
Title: Risk of progressive multifocal leukoencephalopathy in patients with multiple sclerosis treated with low‐dose natalizumab following fingolimod.
Authors: Tanaka, Masami1,2 (AUTHOR) 95masa17777@gmail.com, Nakamichi, Kazuo3 (AUTHOR), Tanaka, Keiko4,5 (AUTHOR)
Source: Clinical & Experimental Neuroimmunology. Aug2025, Vol. 16 Issue 3, p227-235. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17591961
DOI:10.1111/cen3.12820